产品/疗法

树突状细胞疫苗治疗结直肠癌：机制、临床进展与未来方向（综述）

Dendritic cell‑based vaccines for colorectal cancer: Mechanisms, clinical progress and future directions (Review).

前列腺癌的新型免疫治疗

Novel immunotherapies for prostate cancer.

基于树突状细胞的实体瘤免疫治疗

Dendritic Cell-Based Immunotherapy for Solid Tumors.

前列腺癌的细胞免疫治疗：Sipuleucel-T 15 年的经验教训

Cellular Immunotherapy for Prostate Cancer: Lessons Learned From 15 Years of Sipuleucel-T.

sipuleucel-T 在增强转移性去势抵抗性前列腺癌免疫治疗中的协同潜力

Synergistic potential of sipuleucel-T in enhancing immunotherapy for metastatic castration-resistant prostate cancer.

利用 Notch 信号增强人常规 1 型树突状细胞的生成与功能以用于癌症免疫治疗应用

Harnessing Notch Signaling to Enhance the Generation and Functionality of Human Conventional Type 1 Dendritic Cells for Cancer Immunotherapy Applicati

嵌合抗原受体工程化 (CAR)-T 细胞疗法治疗转移性前列腺癌

Chimeric antigen receptor-engineered (CAR)-T cell therapy for metastatic prostate cancer.

转移性前列腺癌的免疫治疗

Immunotherapy in metastatic prostate cancer.

前列腺癌、病理生理学及治疗最新进展：叙述性综述

Prostate Cancer, Pathophysiology and Recent Developments in Management: A Narrative Review.

外周血对 Toll 样受体 1/2 信号的 IFN 反应与接受 Sipuleucel-T 治疗的转移性前列腺癌男性患者更长的生存期相关

Peripheral Blood IFN Responses to Toll-Like Receptor 1/2 Signaling Associate with Longer Survival in Men with Metastatic Prostate Cancer Treated with

转移性去势抵抗性前列腺癌男性患者中 Sipuleucel-T 反应的种族相关差异

Race-Related Differences in Sipuleucel-T Response among Men with Metastatic Castrate-Resistant Prostate Cancer.

高维分析揭示 IL15 增强 Sipuleucel-T 淋巴细胞亚群的活化并逆转免疫抵抗

High-Dimensional Analyses Reveal IL15 Enhances Activation of Sipuleucel-T Lymphocyte Subsets and Reverses Immunoresistance.

癌症疫苗：一种革新的癌症治疗方法

Cancer Vaccines: A Novel Revolutionized Approach to Cancer Therapy.

前列腺癌的新兴治疗选择

Emerging treatment options for prostate cancer.

转移性去势抵抗性前列腺癌（mCRPC）的治疗格局已超越在 ARPI 和/或多西他赛基础上加用其他药物，还包括 sipuleucel-T、镭、卡巴他赛、PARP 抑制剂和镥等其他治疗，这些治疗具有特定适应证及在序贯治疗中的作用。在镥治疗后进展的患者中，仍迫切需要新型疗法。

前列腺癌免疫治疗中癌症疫苗的进展

Advances in cancer vaccines for immunotherapy of prostate cancer.

信号传导新治疗机会：前列腺癌中的细胞因子

Signaling new therapeutic opportunities: cytokines in prostate cancer.

基于细胞因子的疗法提供了一种替代性免疫策略，可靶向 T 细胞之外的多效性前列腺癌肿瘤微环境。未来前列腺癌的免疫治疗策略应针对这些免疫细胞群体，它们可能在前列腺癌肿瘤微环境中发挥更重要的作用。

治疗耐药前列腺癌中的免疫治疗与免疫抑制信号

The Immunotherapy and Immunosuppressive Signaling in Therapy-Resistant Prostate Cancer.

癌症免疫治疗不良事件的新兴管理方法

Emerging Management Approach for the Adverse Events of Immunotherapy of Cancer.

转移性激素敏感性前列腺癌的联合治疗：三者是否过多？

Combination therapy in metastatic hormone-sensitive prostate cancer: is three a crowd?

非洲裔男性前列腺癌背后的免疫机制：综述

Immune mechanisms behind prostate cancer in men of African ancestry: A review.

AA 前列腺癌患者可能富集免疫原性表型。